Who are Rapport Therapeutics, Inc.'s main suppliers?

Rapport Therapeutics, Inc. (RAPP) key suppliers include: NEUROPACE, NEUROPACE-INC, JANSSEN-PHARMACEUTICAL-NV, Lexicon Pharmaceuticals, Inc., Lexicon Pharmaceuticals, Inc. and 7 more. View the full supplier network at chainsifter.com/chain/RAPP.

Who are Rapport Therapeutics, Inc.'s major customers?

Rapport Therapeutics, Inc. (RAPP) key customers include: TENACIA-BIOTECHNOLOGY-HONG-KONG-CO-LTD, NeuroPace, Inc., Xenon Pharmaceuticals Inc.. View the full customer network at chainsifter.com/chain/RAPP.

What sector is Rapport Therapeutics, Inc. in?

Rapport Therapeutics, Inc. (RAPP) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

RAPP Supply Chain: Rapport Therapeutics, Inc. Supplier List & 16 Relationships

12Suppliers

3Customers

1Debt Items

17Related Chains

Rapport Therapeutics, Inc. Suppliers

Ticker	Name	Confidence	Evidence
NEUROPACE	NEUROPACE	92%	Pursuant to the payment schedule set out in the NeuroPace SOWs, the Company will pay NeuroPace an aggregate of up to $ 5.8 million over a period of approximately four years in connection with NeuroPa…
NEUROPACE-INC	NEUROPACE-INC	90%	Pursuant to the NeuroPace Agreement and in accordance with statement of work agreements entered into from time to time, NeuroPace provides us with certain services with respect to data from the RNS s…
JANSSEN-PHARMACEUTICAL-NV	JANSSEN-PHARMACEUTICAL-NV	85%	In August 2022, we entered into an option and license agreement with Janssen Pharmaceutical NV, as amended on April 3, 2023, April 18, 2023, May 2, 2023, October 2, 2023, and April 9, 2024 (collectiv…
LXRX	Lexicon Pharmaceuticals, Inc.	72%	into longer-term commercial supply agreements to fulfill and secure our production needs. While the drug substances used in our product candidates are manufactured by more than one supplier, the numb…
LXRX	Lexicon Pharmaceuticals, Inc.	72%	Reciprocal relationship from LXRX graph: Reciprocal relationship from RAPP graph: into longer-term commercial supply agreements to fulfill and secure our production needs. While the drug substances u…
NPCE	NeuroPace, Inc.	72%	Reciprocal relationship from NPCE graph: Reciprocal relationship from RAPP graph: Reciprocal relationship from NPCE graph: Reciprocal relationship from RAPP graph: Reciprocal relationship from NPCE g…
PRAX	Praxis Precision Medicines, Inc.	72%	into longer-term commercial supply agreements to fulfill and secure our production needs. While the drug substances used in our product candidates are manufactured by more than one supplier, the numb…
PRAX	Praxis Precision Medicines, Inc.	72%	Reciprocal relationship from PRAX graph: Reciprocal relationship from RAPP graph: into longer-term commercial supply agreements to fulfill and secure our production needs. While the drug substances u…
SUPN	Supernus Pharmaceuticals, Inc.	72%	into longer-term commercial supply agreements to fulfill and secure our production needs. While the drug substances used in our product candidates are manufactured by more than one supplier, the numb…
SUPN	Supernus Pharmaceuticals, Inc.	72%	Reciprocal relationship from SUPN graph: Reciprocal relationship from RAPP graph: Reciprocal relationship from SUPN graph: Reciprocal relationship from RAPP graph: Reciprocal relationship from SUPN g…
XENE	Xenon Pharmaceuticals Inc.	72%	into longer-term commercial supply agreements to fulfill and secure our production needs. While the drug substances used in our product candidates are manufactured by more than one supplier, the numb…
XENE	Xenon Pharmaceuticals Inc.	72%	Reciprocal relationship from XENE graph: Reciprocal relationship from RAPP graph: Reciprocal relationship from XENE graph: Reciprocal relationship from RAPP graph: Reciprocal relationship from XENE g…

Rapport Therapeutics, Inc. Customers

Ticker	Name	Confidence	Evidence
TENACIA-BIOTECHNOLOGY-HONG-KONG-CO-LTD	TENACIA-BIOTECHNOLOGY-HONG-KONG-CO-LTD	90%	The arrangement provides Tenacia with the exclusive rights to develop and commercialize the Company’s product candidate, RAP-219
NPCE	NeuroPace, Inc.	72%	Reciprocal relationship from NPCE graph: ody of peer-reviewed publications and scientific research involving our RNS System. We also engage in direct-to-patient marketing activities including targete…
XENE	Xenon Pharmaceuticals Inc.	72%	Reciprocal relationship from XENE graph: Reciprocal relationship from RAPP graph: Reciprocal relationship from XENE graph: Reciprocal relationship from RAPP graph: Reciprocal relationship from XENE g…

Rapport Therapeutics, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
RAPP-DEBT	Debt stack $10.8M	90%	Market cache reports total debt of $10.8M.

Rapport Therapeutics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Rapport Therapeutics, Inc..

Rapport Therapeutics, Inc. Ownership

Holder	Name	Confidence	Evidence
RAPP-OWNER-FMR-LLC	FMR LLC	90%	13F overlay lists FMR LLC as top holder; 148 tracked holders.

Rapport Therapeutics, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
LXRX	Lexicon Pharmaceuticals, Inc.	100.00	1	['supplier']
NPCE	NeuroPace, Inc.	100.00	1	['customer', 'supplier']
XENE	Xenon Pharmaceuticals Inc.	100.00	1	['customer', 'supplier']
BHC	Bausch Health Companies Inc.	50.00	2
ORANY	ORANGE	50.00	2
NVO	Novo Nordisk A/S	50.00	2
SUPN	Supernus Pharmaceuticals, Inc.	50.00	2	['supplier']
BMY	Bristol-Myers Squibb Company	50.00	2
ANRO	Alto Neuroscience, Inc.	50.00	2
LIVN	LivaNova PLC	50.00	2
NBIX	Neurocrine Biosciences, Inc.	50.00	2
MDT	Medtronic plc	50.00	2
PRAX	Praxis Precision Medicines, Inc.	50.00	2	['supplier']
NMRA	Neumora Therapeutics, Inc.	50.00	2
ITGR	Integer Holdings Corporation	50.00	2
AXSM	Axsome Therapeutics, Inc.	50.00	2
HTGC	Hercules Capital, Inc.	50.00	2

Rapport Therapeutics, Inc. Supply Chain